Table 4.

Body composition change from baseline by obesification group and time point during weight loss.

Change from baseline	4 weeks	8 weeks	12 weeks1
Body weight (kg)
ObN	−1.4 ± 0.6c,#	−2.7 ± 0.8c,$	−3.6 ± 0.9c,$
ObP	−0.4 ± 0.6a,#	−1.3 ± 1.0b,$	−1.1 ± 1.2b,$
WLD	−1.6 ± 0.5c,#	−2.3 ± 1.0c,#	−4.4 ± 1.1c,$
IBW	−1.0 ± 0.6b,#,$	−1.3 ± 0.8a,#	−0.6 ± 0.9a,$
Fat mass (kg)
ObN	−1.2 ± 0.3b,c,#	−2.2 ± 0.4c,$	−3.1 ± 0.6c,$
ObP	−0.4 ± 0.5a,#	−0.8 ± 0.7a,#	−0.9 ± 1.0b,#
WLD	−1.5 ± 0.4c,#	−2.7 ± 0.8c,$	−3.9 ± 0.8c,$
IBW	−0.7 ± 0.3b,#	−1.0 ± 0.6b,#	−0.7 ± 0.7a,#
Body fat (%)
ObN	−3.4 ± 1.3a,b,#	−7.3 ± 1.7c,$	−12.1 ± 3.7c,$
ObP	−0.7 ± 1.0a,#	−2.4 ± 2.2a,#	−2.6 ± 3.2a,#
WLD	−5.2 ± 1.9b,#	−11.7 ± 3.2c,$	−17.0 ± 4.8c,$
IBW	−4.4 ± 2.3c,#	−6.6 ± 4.3b,#	−5.0 ± 4.7b,#
Lean mass (kg)
ObN	−0.5 ± 0.3b,#	−0.6 ± 0.5a,#	−0.6 ± 0.3b,#
ObP	−0.3 ± 0.3a,b,#	−0.3 ± 0.2a,#	−0.4 ± 0.3a,b,#
WLD	−0.4 ± 0.6b,#	−0.4 ± 0.6a,#	−0.4 ± 0.5a,b,#
IBW	−0.1 ± 0.2a,#	−0.04 ± 0.3a,#	−0.05 ± 0.3a,#
Lean (%)
ObN	3.0 ± 1.3a,#	6.7 ± 1.5c,$	11.3 ± 3.4c,$
ObP	0.5 ± 0.8a,#	2.1 ± 2.1a,#	2.4 ± 3.0a,#
WLD	4.8 ± 2.0a,#	10.7 ± 3.3c,$	16.2 ± 4.7c,$
IBW	4.2 ± 2.3b,#	6.3 ± 4.2b,#	4.9 ± 4.6b,#

Numerical data presented as mean ± standard deviation.

ObN, obese nutraceutical group; ObP, obese placebo group; WLD, weight loss diet group; IBW, ideal body weight group.

Except where otherwise indicated, n = 5 for obesification groups (ObN, ObP, WLD) and n = 6 for group IBW.

¹WLD in this column determined from 4 dogs, because 1 dog reached ideal weight and ended treatment at 8 weeks.

^a,b,cWithin a column, values with different superscript letters differ significantly (p < 0.05).

^#,$Across columns, values with different superscript symbols differ significantly (p < 0.05).